BackDaito Pharmaceutical ,Ltd. Overview

Daito Pharmaceutical ,Ltd. Current Assets

Latest current assets for 4577.T: $37B.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$36.63B
↓ 12.18% YoYΔ $-5.08B vs prior year quarter

Peer trimmed avg / median

Loading

Daito Pharmaceutical ,Ltd. Current Assets History

Loading

Daito Pharmaceutical ,Ltd. vs. peers: Current Assets Comparison

Loading

Daito Pharmaceutical ,Ltd. Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Daito Pharmaceutical ,Ltd. (4577.T) FAQ

As of the most recent data (May 2026), 4577.T shows a current assets of $37B. That compares with $42B in the prior-year period — down 12.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4577.T's current assets is now $37B (was $42B) — a 12.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Daito Pharmaceutical ,Ltd. is outperforming or lagging.

Tracking 4577.T's current assets over time shows whether Daito Pharmaceutical ,Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $37B That compares with $42B in the prior-year period — down 12.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Daito Pharmaceutical ,Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $37B) with ownership activity and broader fundamentals.